PERFORMANCE STATUS AND COMORBIDITY AFFECT SURVIVAL IN ELDERLY PATIENTS WITH CLL AFTER LOW DOSE ALEMTUZUMAB COMBINED WITH CHEMOTHERAPY: RESULTS FROM THE HOVON68 TRIAL
Author(s):
Vojdeman, F.; van't Veer, M.; Tjonnfjord, G.; Itala-Remes, M.; Kimby, E.; Polliack, A.; Wu, K.L.; Doorduijn, J.; Alemayehu, W.; Wittebol, S.; Kozak, T.; Walewski, J.; Abrahamse-Testroote, M.; Oers, M. van; Geisler, C.
